Daojing Wang

About

Daojing Wang is the founder and CEO of Newomics, a Berkeley-based biotechnology company commercializing mass spectrometry tools and multiomics platforms for precision medicine. Public materials tie Newomics to technology originating at Lawrence Berkeley National Laboratory and to products used across proteomics, metabolomics, clinical diagnostics, and related LC-MS workflows. Wang appears primarily as a scientific founder and company builder rather than an investor or fund manager.

Areas of interest